Preclinical and First-In-Human Phase I Studies of KW-2450, an Oral Tyrosine Kinase Inhibitor With Insulin-Like Growth Factor Receptor-1/Insulin Receptor Selectivity

Cancer Science - United States
doi 10.1111/cas.12906
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Insulin-Like Growth Factor-I Receptor Blockade by a Specific Tyrosine Kinase Inhibitor for Human Gastrointestinal Carcinomas

Molecular Cancer Therapeutics
Cancer ResearchOncology
2008English

Preclinical and Phase I Clinical Studies of KW-2450, a Dual IGF-1R/IR Tyrosine Kinase Inhibitor, in Combination With Lapatinib and Letrozole

Therapeutic Advances in Medical Oncology
Oncology
2018English

GβγSubunits Mediate Mitogen-Activated Protein Kinase Activation by the Tyrosine Kinase Insulin-Like Growth Factor 1 Receptor

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

Clinical Phase I Study With an Insulin-Like Growth Factor-1 Receptor Inhibitor: Experiences in Patients With Squamous Non-Small Cell Lung Carcinoma

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2010English

Insulin Receptor Substrate-2 Mediated Insulin-Like Growth Factor-I Receptor Overexpression in Pancreatic Adenocarcinoma Through Protein Kinase C

Cancer Research
Cancer ResearchOncology
2009English

C-Terminal SRC Kinase Associates With Ligand-Stimulated Insulin-Like Growth Factor-I Receptor

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1999English

Insulin-Like Growth Factor-I-Induced DNA Synthesis in Insulin-Secreting Cell Line RINm5F Is Associated With Phosphorylation of the Insulin-Like Growth Factor-I Receptor and the Insulin Receptor Substrate-2

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
1998English

Antiapoptotic Signalling by the Insulin-Like Growth Factor I Receptor, Phosphatidylinositol 3-Kinase, and Akt.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1997English

Mutational Analysis of the Insulin-Like Growth Factor 1 Receptor Tyrosine Kinase Domain in Non-Small Cell Lung Cancer Patients

Molecular and Clinical Oncology
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy